Trade Summary

6 days ago, Ellis Andrea, serving as Dir at BridgeBio Pharma, Inc. (BBIO), sold 17,167 shares at $84.00 per share, for a total transaction value of $1,442,028.00. Following this transaction, Ellis Andrea now holds 22,579 shares of BBIO.

This sale represents a 43.19% decrease in Ellis Andrea's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 9, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 13, 2026 at 4:41 PM ET, 4 days after the trade was made.

BridgeBio Pharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.